Not Signed In - Invasive Fungal Infections - CHMP Adopts Positive Opinion for NOXAFIL(R) (posaconazole) Oral Suspension
Mon, 01 Aug 2005 12:00 AM EST
... Schering-Plough Corporation reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of NOXAFIL(R) (posaconazole) Oral Suspension for the treatment of certain serious invasive fungal infections in adult patients with refractory disease (failed prior therapy) or who are intolerant to other therapy... click link for more info. ...
Related Topics
- Fungal Infections
- Fungal Infections & Diseases
- Amoxicillin Oral Suspension
- Fungal Diseases
- Aluminum and Magnesium Hydroxide Oral Suspension
- Erythromycin Oral Suspension
- Megestrol Oral Suspension
- Tetracycline Oral Suspension
- Nystatin Oral Suspension
- Famotidine Oral Suspension
- Azithromycin Oral Suspension
- Griseofulvin Oral Suspension
- Rofecoxib Oral Suspension
- Sulfisoxazole Oral Suspension or Syrup
- Lansoprazole Oral Suspension
- Ampicillin Oral Suspension
- Brompheniramine Oral Suspension
- Acyclovir Oral Suspension
- Diazoxide Oral Suspension
- Felbamate Oral Suspension
email this page
print this page
bookmark this page
feedback on this page
